Amarin--2019's Biggest Buyout Target for Big Pharma
Amarin (AMRN US), a US-listed biotech firm, presented the full results of its "Reduce-It" (RI) clinical trial at a conference for the American...
4.8k Views
Nihon Nohyaku: Adeka Offer Price Seems Full, but Longer-Term Outlook Makes Valuation Fair
We visited Nihon Nohyaku (4997 JP) ("Nichino") this week to discuss the company's longer-term strategy and gain a deeper understanding of its...
578 Views
Adeka Partial TOB for Nihon Nohyaku: LT Fundamentals for These Strong Niche Players Are Good
After market close on the 21st Adeka Corp (4401 JP) announced a partial tender offer (and participation in a third party allotment) to make Nihon...
653 Views
Sector Capsule: Pet Products in the Philippines
Pet products recorded 9% current value growth to reach sales of PHP1.2 billion in 2017. The willingness of pet owners to ensure the overall...
217 Views
Sector Capsule: Pet Products in Thailand
Pet products in Thailand registered value growth of 14% in current value terms to reach THB2.6 billion in 2017. Pet humanisation is the driving...
198 Views